AMG 172 First in Human Study in Patients With Kidney Cancer

Clinical trial NCT01497821 · COMPLETED

Trial details

NCT number: NCT01497821
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Adenocarcinoma Clear Cell Renal Carcinoma Clear Cell Renal Cell Carcinoma Renal Cell Carcinoma

Start date: 2012-01-01
Primary completion: 2014-11-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.